Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (4578)	2/3/2006 8:16:35 PM
From: LJM	Read Replies (1) of 4974

Wow, you got that right. >>NeoRx stock climbs after financing announcement Friday February 3, 1:38 pm ET Shares in NeoRx Corp. rose more than 30 percent in early trading Friday, following an announcement that the Seattle biotech signed a deal for $65 million in new private financing. The $65 million private placement of newly issued shares of stock and the issuance of warrants for the purchase of additional shares of stock is being led by MPM Capital of Boston and San Francisco. After the deal closes, MPM Capital will own 30 percent of the cancer drug company's stock (NASDAQ: NERX - News) and will fill a director's seat on the NeoRx board of directors. NeoRx also received a $3.5 million bridge loan that company officials said will be used for working capital. On Friday, the stock was trading in the range of $1.10 per share, up 26 cents. In early January, NeoRx received a delisting notice from the NASDAQ stock exchange because its stock fell below $1 for 30 straight business days.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next